Biosurfit

1 known investors

Biosurfit develops point-of-care diagnostic technology that produces lab-quality results from a single finger-prick blood sample. Its disposable disc platform can combine immunoassays, haematology, and clinical chemistry analytes in one test to support physicians' diagnostic and treatment decisions.